XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis.

Blood Cancer J · 2021 · PMC7873181 · PMID 33563902

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

showed a trendp = 0.08so close (0.05 < p ≤ 0.1)

In agreement with a protective role for apoptosis in ATL, CASP10 levels showed a trend of correlation to longer survival (r = 0.64, p = 0.08), which remains to be investigated in larger cohorts.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.